AIRNA: Funding, Investors & Team (Sep 2026)
AIRNA is an innovative biotech firm focused on developing RNA editing treatments to enhance the well-being of individuals experiencing various uncommon and widespread medical conditions.
AIRNA has raised $185M across 2 funding rounds on record, the most recent a Series B of $155M announced in Apr 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AIRNA Company Profile and Key Stats
Latest funding round on record: Apr 2025.
AIRNA Funding Rounds
AIRNA raised $30.0M in a Series A announced in Sep 2023.
1.6 years later, a Series B of $155M was announced in Apr 2025.
AIRNA Founders and Leadership Team
Contact details for the AIRNA team: 2 of 2 have an email address on file.
Start 14-day free trial →AIRNA Funding Compared to Other Biotechnology Startups
AIRNA's latest round of $155M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AIRNA in Biotechnology and Cambridge
Companies Similar to AIRNA
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
AIRNA Funding FAQs
What does AIRNA do?
AIRNA is an innovative biotech firm focused on developing RNA editing treatments to enhance the well-being of individuals experiencing various uncommon and widespread medical conditions.
How much funding has AIRNA raised?
AIRNA has raised $185M across 2 rounds on record. The most recent is a Series B of $155M announced in Apr 2025.
When did AIRNA last raise funding?
AIRNA's most recent funding round on record is a Series B of $155M, announced in Apr 2025.
Who founded AIRNA?
FundedIQ lists Tobias Merkle (Founder) at AIRNA.
Who is the CEO of AIRNA?
Kris Elverum is listed as CEO at AIRNA.
Where is AIRNA headquartered?
AIRNA is based in Cambridge, Massachusetts, United States.
How many employees does AIRNA have?
AIRNA is in the 11-50 employee band.
How does AIRNA's funding compare to other Biotechnology startups?
AIRNA's latest round of $155M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's AIRNA Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AIRNA is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.